Form 4/A for TXMD TherapeuticsMD, Inc.
Accepted 2023-05-04 00:00:00 ET · period of report 2023-04-12 · accession 0001209191-23-027361 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMA | 2023-05-04 | 2023-04-26 | TXMD | Walker Marlan D | CEO | M - OptEx | $0.00 | +2,744 | 14.0K | +24% | $0 |
| DA | 2023-05-04 | 2023-04-26 | TXMD | Walker Marlan D | CEO | S - Sale+OE | $3.64 | -692 | 11.6K | -6% | -$2,519 |
| DMA | 2023-05-04 | 2023-04-26 | TXMD | Walker Marlan D | CEO | M - OptEx | $0.00 | -2,744 | 3,466 | -44% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-26 | M | A | 1,734 | $0.00 | 12,307 | D | — | — | (F1) The beneficially owned shares have been adjusted as the restricted stock units previously reported as settled on April 12, 2023 were not settled on that date. The restricted stock units settled on April 26, 2023. |
| 2 | Common | Common Stock | 2023-04-26 | M | A | 1,010 | $0.00 | 14,041 | D | — | — | (F1) The beneficially owned shares have been adjusted as the restricted stock units previously reported as settled on April 12, 2023 were not settled on that date. The restricted stock units settled on April 26, 2023. |
| 3 | Common | Common Stock | 2023-04-26 | S | D | 692 | $3.64 | 11,615 | D | — | — | |
| 4 | Derivative | Restricted Stock Units | 2023-04-26 | M | D | 1,010 | $0.00 | 0 | D | $0.00 · — to — | 1,010 Common Stock | (F3) Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs vested in three equal installments annually, becoming fully vested on March 30, 2023. |
| 5 | Derivative | Restricted Stock Units | 2023-04-26 | M | D | 1,734 | $0.00 | 3,466 | D | $0.00 · — to — | 1,734 Common Stock | (F4) Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025. |